While vitamin A and its derivatives may play an important role in experimental carcinogenesis (Goodman, 1980; Sporn & Roberts, 1983) , much less is known about the relationship between vitamin A and cancer in man. The bulk of evidence to support the existence of such a relation derives from studies on dietary habits and cancer incidence (Bjelke, 1975; Mettlin et al., 1979) and from those of retinol levels in sera of cancer patients (Wald et al., 1980; Kark et al., 1981) . Initial studies suggested that low serum retinol levels might indicate an increased risk of developing cancer. However, more recent studies failed to confirm an inverse association between serum retinol level and overall cancer incidence (Willet et al., 1984; Peleg et al., 1984) .
Our previous study (Sawicki et al., 1985) and those of others (Atukorala et al., 1979; Ibrahim et al., 1977) showed that serum retinol levels were lower in colorectal cancer patients than in healthy controls. The decreased retinol level in cancer patients can be a primary or secondary phenomenon, for example, a result of decreased intestinal absorption or of impaired release of vitamin A from liver storage. An alternative explanation might be that decreased serum retinol level is associated with host metabolic changes induced by the neoplastic process. If this were true, one might expect a negative correlation between serum retinol level and tumour burden. The purpose of this study was to test this latter hypothesis by determining serum retinol level in patients with benign or malignant colonic polyps and in those with colorectal cancers of differing stage.
Materials and methods
Three hundred and twenty subjects, assigned to 5 groups, were studied. Serum retinol levels were determined by the fluorometric method of Thompson et al. (1971) Table I ). bSignificance of difference from pre-surgery value, P <0.01.
inflammatory bowel disease had significantly decreased mean serum retinol levels compared to control patients (P < 0.01). The patients with benign or malignant colonic polyps had serum retinol levels which did not differ from those of controls. Table II shows retinol levels in the sera of colorectal cancer patients that were divided according to the modified Dukes' classification. Serum retinol levels were significantly decreased only in patients with disease stage C or D (P<0.01).
Serum retinol levels in 18 cancer patients before and in three period intervals after surgery are shown in Table III . Before surgery, the cancer patients had decreased mean serum retinol level compared to controls (P<0.01), whereas after surgery they had almost normal levels regardless of the length of follow-up. Their serum retinol levels determined 1-3 months after surgery were probably significantly higher than levels before surgery (P< 0.05), and in further-follow-up periods were significantly higher (P<0.01) using the paired t-test.
A distinctive group comprised 21 previously treated patients who died of metastases during the follow-up period. Their retinol levels determined 3-6 months after surgery (3-20 months before death) were very low both in those with synchronous (9 patients) and metachronous (12 patients) metastases (42.6 and 37.0 jg 100 ml-1, respectively).
Discussion
Our study revealed significantly lower retinol levels in the sera of colorectal cancer patients and those with inflammatory bowel disease, than of controls. The retinol levels were similar in patients with benign or malignant colorectal polyps and did not differ from those found in controls. When colorectal cancer patients were divided according to Dukes' classification, those with stage B tumours had almost normal retinol levels, whereas those with C or D stage tumours had significantly lower levels compared to control patients. These data suggest that there is a negative correlation between the degree of advancement of colorectal cancer and serum retinol level. Consequently, the decreased serum retinol level may be a secondary rather than a primary phenomenon in cancer patients, possibly induced by the tumour itself. Further support for such a hypothesis is provided by the results obtained in our treated patients in whom the mean serum retinol levels estimated postoperatively did not differ from those obtained in controls.
Our results are different from those obtained by Basu et al. (1985) who reported low serum retinol levels in their postoperative patients, who were otherwise free of disease. Among our postoperative patients, serum retinol levels were decreased only in those who died of metastases during follow-up. In the remaining colorectal cancer patients who appeared to be disease-free, serum retinol levels significantly increased to control values. All of the latter patients had normal calorific nutrition in the postoperative period as judged by dietary interview. An improvement in the nutritional state was observed during follow-up. However, there was no correlation between their serum retinol level and body weight.
It is difflcult to explain the difference between the two studies; one possibility is that serum storage time may influence the determination of retinol levels. In our study sera were not stored longer than two weeks.
In patients with inflammatory bowel disease, serum retinol levels correlated with clinical activity of the disease to the extent that the lowest values were found in patients with very active disease. These findings confirmed earlier results of others for patients with Crohn's disease (Main, 1983; Schoelmerich, 1985) . Furthermore, low serum retinol levels were found in patients with chronic pancreatitis or cholecystitis and in those with acute febrile illnesses (unpublished data). Since retinol binding protein has a relatively short half-life, its synthesis is sensitive to protein and/or energy deprivation, causing a decrease in serum retinol level. It seems, therefore, that the majority of our patients with low serum retinol level had impairment of protein energy balance similar to that in hunger and postaggression metabolism.
In conclusion, our results indicate that decreased serum retinol levels in colorectal cancer patients is secondary to the disease rather than vice versa. The mechanism of this decrease is, as yet, unknown. It can only be speculated that low retinol levels in the sera of colorectal cancer patients results from an interaction of an enlarging tumour mass and a host factor(s) such as increased protein catabolism or inflammation.-Furthermore, this study suggests that a dramatic decrease in serum retinol level in the postoperative period can be an indicator of a poor prognosis in patients with colorectal cancer.
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